%0 Journal Article
%T A phase Ib dose-finding, pharmacokinetic study of the focal adhesion kinase inhibitor GSK2256098 and trametinib in patients with advanced solid tumours
%J -
%D 2019
%R https://doi.org/10.1038/s41416-019-0452-3
%X Combined focal adhesion kinase (FAK) and MEK inhibition may provide greater anticancer effect than FAK monotherapy
%U https://www.nature.com/articles/s41416-019-0452-3